Patents by Inventor CharChang Lai

CharChang Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ICP0-mediated enhanced expression system
    Patent number: 11286465
    Abstract: Methods and compositions for increasing the production of recombinant proteins by introducing ICP0 to cells capable of producing a recombinant protein are encompassed. In one method, the recombinant protein is a protein that is required for the replication of a replication defective virus, wherein the recombinant protein is provided to the replication defective virus in trans.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: March 29, 2022
    Assignee: SANOFI PASTEUR INC.
    Inventors: Simon Delagrave, CharChang Lai
  • ICP0-MEDIATED ENHANCED EXPRESSION SYSTEM
    Publication number: 20190194626
    Abstract: Methods and compositions for increasing the production of recombinant proteins by introducing ICP0 to cells capable of producing a recombinant protein are encompassed. In one method, the recombinant protein is a protein that is required for the replication of a replication defective virus, wherein the recombinant protein is provided to the replication defective virus in trans.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 27, 2019
    Applicant: Sanofi Pasteur Biologics, LLC
    Inventors: Simon Delagrave, CharChang Lai
  • ICP0-mediated enhanced expression system
    Patent number: 10208292
    Abstract: Methods and compositions for increasing the production of recombinant proteins by introducing ICP0 to cells capable of producing a recombinant protein are encompassed. In one method, the recombinant protein is a protein that is required for the replication of a replication defective virus, wherein the recombinant protein is provided to the replication defective virus in trans.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: February 19, 2019
    Assignee: Sanofi Pasteur Biologics, LLC
    Inventors: Simon Delagrave, CharChang Lai
  • ICP0-MEDIATED ENHANCED EXPRESSION SYSTEM
    Publication number: 20180119111
    Abstract: Methods and compositions for increasing the production of recombinant proteins by introducing ICP0 to cells capable of producing a recombinant protein are encompassed. In one method, the recombinant protein is a protein that is required for the replication of a replication defective virus, wherein the recombinant protein is provided to the replication defective virus in trans.
    Type: Application
    Filed: May 12, 2016
    Publication date: May 3, 2018
    Inventors: Simon Delagrave, CharChang Lai